Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGE-175 in Hospitalized COVID-19
NCT04705597Phase 2Terminated
- Sponsor
- BioAge Labs
- Start
- Mar 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of asapiprant in coronavirus disease 2019 (COVID-19), sponsored by BioAge Labs. Started Mar 2021; status: terminated.
02
Drugs
asapiprant
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04705597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04705597.